Showing posts with label Alzheimer's. Show all posts
Showing posts with label Alzheimer's. Show all posts

3.24.2008

Sage improves memory and attention

'He that would live for aye,
Must eat Sage in May.'
The old English proverb, quoted by venerable herbalists from Gerard to Maude Grieve, refers to the virtues of the common garden sage (Salvia officinalis). This gracious aromatic herb, of a dry and warming energy, was long considered to confer immortality, a quickness of wit and eye, and protection from disease.
Previous research has shown evidence for sage's ability to enhance mood, reduce anxiety, and improve performance in healthy young volunteers (lemon balm, too), and the in-vitro research on the herb's ability to exert anti-cholinesterase activity (prolonging the activity of the neurotransmitter acetylcholine) has made it a target for research in aging and dementia. Acetylcholine is involved in transmitting signal in an area of the brain called the basal forebrain (amongst others), and there is evidence that this region of the central nervous system degrades as we age, leading to memory loss and cognitive impairment (as in Alzheimer's, for instance). Acetylcholine also provides the connection between the nervous system and musculature, and deficiencies are associated with conditions such as myasthenia gravis.
In this most recent study, 20 healthy older volunteers aged 65 to 90 were given various doses of a sage extract, and the results indicate an improvement in a variety of cognitive markers, along with a reduction in the score dropoff over the course of the day (the volunteers stayed sharper, longer). Some details:
  • the extract was made with 70% alcohol, then concentrated and freeze-dried to a final weight-to-volume ratio of 7.5:1. This is pretty darn concentrated. Researchers were going for the volatile terpenes primarily (well-soluble in alcohol). They found 333mg to be the most effective dose; this is about 2.5 grams of leaf, or about 7.5 ml (1 and 1/2 tsp.) of a 1:3 tincture of sage.
  • the extract was compared to placebo, in a variety of categories including word recognition and recall; vigilance; reaction time; spatial and numeric memory; and delayed picture recognition tests. Below are graphs of the changes in (a)secondary memory and (b)accuracy of attention:









So, sage is definitely worth considering in the context of other herbs such as Ginkgo and Rhodiola in helping buffer the effects of aging on otherwise healthy minds. Perhaps there is indeed some wisdom in the old Latin proverb, Cur moriatur homo cui Salvia crescit in horto? ('Why should a man die as long as sage grows in his garden?'). Or at least, why should he (or she) grow old and forgetful?

7.18.2007

Curcumin and Alzheimer's

Though these findings come from a test tube, the results are nonetheless pretty interesting: a study carried out at UCLA reveals that immune cells are much more active against the amyloid plaques thought to contribute to Alzheimer's disease when treated with curcumin, one of the many compounds in turmeric.
This delicious rhizome in the ginger family has been conclusively shown to have anti-inflammatory power, and now this in-vitro research seems to hint at power beyond simple reduction of inflammation.
Amyloid plaques, which are tangles of protein thought to interfere with neuronal function in Alzheimer's disease, have a close link to inflammatory processes. Perhaps ongoing ingestion of turmeric in the diet can have a protective effect if initiated early on in life. I'd be interested in epidemiological reviews of the incidence of Alzheimer's in cultures who use a lot of curry (rich in turmeric) versus those who use none...

11.16.2006

Ginkgo and Alzheimer's

The leaves of Ginkgo biloba have an extensive reasearch history behind them, although their therapeutic use is fairly recent. Though many claims have been made about this ancient tree (mostly relating to memory, energy, mental function), there are some clear indications and effects that almost everyone agrees on: first, ginkgo increases circulation; second, it has a marked antioxidant and cell-protective effect; third, it influences biochemical mechanisms in the blood resulting in an net reduction of clotting power.
Recently, based primarily on the first two facts listed above, researchers have been focusing on ginkgo's use in treating Alzheimer's-related dementia. A trial released in 2004 showed promising results and began to elucidate some of the mechanisms in the brain (relating to neurotransmitter activity and the reduction of protein tangles) that contributed to its positive effect. Now, a new trial in the European Journal of Neurology (those Europeans, always messing around with herbs...) confirms the previous results and lends more credence to ginkgo as a good treament for slowing the progress of Alzheimer's disease. It also reinforces the idea that ginkgo has the effect of increasing ACh (acetylcholine, an important neurotransmitter in the brain and body) sensitivity, and is much better tolerated than the prescription drugs that are currently used.

10.20.2006

Cannabinoids and Alzheimer's

A preliminary study seems to imply that the use of cannabinoids (one of the many biochemically active agents in marijuana) can protect the brain from inflammatory degeneration and its complications, such as Alzheimer's disease. The current study relies on an animal model and requires the consumption of cannabinoids during youth - but in that particular situation, the results are a dramatic reduction in the changes in brain tissue that lead to the formation of amyloid plaque, thought to be a chief culprit in Alzheimer's.
Gary Wenk, Ph.D, conducted the research at the University of Ohio:

... as the animals age, Dr. Wenk said, they develop inflammation in parts of the brain analogous to the parts damaged by inflammation in people with Alzheimer's.

Recent research in other fields suggested that cannabinoids -- the active ingredients in marijuana -- can cross the blood-brain barrier, even at low doses, and can reduce inflammation, Dr. Wenk said.

So, in young rats, Dr. Wenk and colleagues created brain inflammation by infusing nanogram quantities of lipopolysaccharide and then treated them with a synthetic cannabinoid called WIN-55212-2.

"We saw an 80% to 90% drop in the inflammation in the brain," he said, "and also the impairment in memory that inflammation produces could be reversed."

http://www.medpagetoday.com/Neurology/AlzheimersDisease/tb2/4321